A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

Made in the USA, a new daily oral weight-loss pill from Eli Lilly won't require cold storage and is expected to hit markets ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at ...

Eli Lilly & Co. plans to manufacture its new weight-loss pill in the US for patients around the world as President Donald ...

Lilly announced the results of its first of seven clinical trials of orforglipron, the new GLP-1 agonist pill that aims to ...

the new GLP-1 agonist pill that aims to lower blood sugar in people with Type 2 diabetes and help with weight loss in people who are clinically obese. Currently, GLP-1 agonists like Ozempic and ...

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages ... for use by people around the world." Lilly's shares had ...